These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 20706056)
1. Chest wall and axillary lymph node FDG uptake associated with cancer vaccine therapy for lung cancer. Kaneko K; Yoshida T; Hiyama J; Ono K; Omagari J Clin Nucl Med; 2010 Sep; 35(9):729-30. PubMed ID: 20706056 [TBL] [Abstract][Full Text] [Related]
2. Tumour and lymph node uptakes on dual-phased 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography correlate with prognostic parameters in breast cancer. Chang CC; Tu HP; Chen YW; Lin CY; Hou MF J Int Med Res; 2014 Dec; 42(6):1209-21. PubMed ID: 25339454 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer. Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198 [TBL] [Abstract][Full Text] [Related]
4. FDG uptake in the chest wall of a patient with small-cell lung cancer. Stigt JA; Boomsma MF; van Bemmel BC J Thorac Oncol; 2013 Jun; 8(6):806-7. PubMed ID: 23676559 [No Abstract] [Full Text] [Related]
5. 18F-FDG PET definition of gross tumor volume for radiotherapy of lung cancer: is the tumor uptake value-based approach appropriate for lymph node delineation? Rodríguez N; Sanz X; Trampal C; Foro P; Reig A; Lacruz M; Membrive I; Lozano J; Quera J; Algara M Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):659-66. PubMed ID: 20133071 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer. Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375 [TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of (18)F-FDG PET-CT in evaluation of the therapeutic efficacy of chemotherapy for lung cancer]. Jia P; Guo WH; Zhang Y Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):235-6. PubMed ID: 19615270 [No Abstract] [Full Text] [Related]
8. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp LJ; Comans EF; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Nowak PJ; van Herk M; Rasch CR Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):435-48. PubMed ID: 16198064 [TBL] [Abstract][Full Text] [Related]
9. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
10. Detection of an asymptomatic right-ventricle cardiac metastasis from a small-cell lung cancer by F-18-FDG PET/CT. Orcurto MV; Delaloye AB; Letovanec I; Martins Favre M; Prior JO J Thorac Oncol; 2009 Jan; 4(1):127-30. PubMed ID: 19096320 [TBL] [Abstract][Full Text] [Related]
11. Radiation treatment planning using positron emission and computed tomography for lung and pharyngeal cancers: a multiple-threshold method for [(18)F]fluoro-2-deoxyglucose activity. Okubo M; Nishimura Y; Nakamatsu K; Okumura M; Shibata T; Kanamori S; Hanaoka K; Hosono M Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):350-6. PubMed ID: 20457349 [TBL] [Abstract][Full Text] [Related]
12. Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging. Taira N; Ohsumi S; Takabatake D; Hara F; Takashima S; Aogi K; Takashima S; Inoue T; Sugata S; Nishimura R Jpn J Clin Oncol; 2009 Jan; 39(1):16-21. PubMed ID: 18997183 [TBL] [Abstract][Full Text] [Related]
14. Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer. Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H Anticancer Res; 2016 Jan; 36(1):393-7. PubMed ID: 26722071 [TBL] [Abstract][Full Text] [Related]
15. Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer. Gil-Rendo A; Zornoza G; García-Velloso MJ; Regueira FM; Beorlegui C; Cervera M Br J Surg; 2006 Jun; 93(6):707-12. PubMed ID: 16622900 [TBL] [Abstract][Full Text] [Related]
16. Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era. Garcia C; Flamen P Curr Opin Oncol; 2008 May; 20(3):275-9. PubMed ID: 18391626 [TBL] [Abstract][Full Text] [Related]
17. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3. Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480 [TBL] [Abstract][Full Text] [Related]
18. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254 [TBL] [Abstract][Full Text] [Related]
19. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738 [TBL] [Abstract][Full Text] [Related]